TB-500 is a synthetic version of Thymosin Beta-4, a protein known for its potent healing properties. It facilitates rapid recovery from injuries and is commonly used in research settings to study performance improvement and injury reduction. Originally explored in human applications since 1974, TB-500 has been utilized to accelerate recovery and decrease swelling in various models.
TB-500 functions by regulating actin, a protein crucial for cell building, particularly in muscle formation. It works synergistically with myosin to enhance metabolism and motion. Key benefits observed in research include decreased injury recovery time, reduced chronic inflammation, improved heart health, support for brain function, and faster wound healing. Potential drawbacks noted in studies include lightheadedness, nausea, and stomach cramps, though these are context-dependent.
For research use, TB-500 is typically supplied as a powder that requires reconstitution with bacteriostatic water. The process involves sanitizing containers, mixing carefully to avoid direct powder contact, and calculating dosages based on concentration. It can be administered via intramuscular, subcutaneous, or intravenous injection, depending on the experimental protocol.
This product is intended for research purposes only and not for personal use. Ensure proper handling and storage to maintain integrity and efficacy.